Outcomes and Follow-up after Hepatitis C Eradication with DAAs
EASL Guidelines advise hepatitis C virus (HCV) RNA in PW1bs or men who have sex with men with ongoing risk behavior (A1). Current direct-acting antivirals (DAAs)-based regimens are highly effective and safe. Early treatment halt the progression to cirrhosis and allow for a decrease in healthcare costs. HCV eradication can prevent the complications of liver cirrhosis and extrahepatic manifestations. Noninvasive tests can predict the onset of complications. Ideal followup after sustained virologic response in patients with advanced liver disease and cirrhosis is still debated.
Dr. Fransesco Paolo Russo
Dr. Fransesco Paolo Russo is an Assistant Professor of Gastroenterology University Hospital Padova. He has completed MEDICAL DEGREE: School of Medicine, University of the Study Padua (Italy), conferred on October 1997 Visiting medical student: Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands. August 1996 Visiting medical student: Indiana University Medical Center, Department of Medicine, Division of Gastroenterology/Hepatology, University Hospital, Indianapolis, USA. August September1995, DIPLOMA: Scientific High School.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article